During the past decade, Himorogi Psychiatric Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Himorogi Psychiatric Institute" are "Depressive Episodes, Bipolar I Depression" (2 trials), "Borderline Personality Disorder" (1 trials) and "Depressive Disorder, Major" (1 trials). Many other conditions were trialed in "Himorogi Psychiatric Institute" in a lesser frequency.

Most popular intervention types in "Himorogi Psychiatric Institute" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BI 1358894" (2 trials), "Quetiapine" (1 trials), "SEP-4199 CR" (1 trials) and "SEP-4199 CR 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Himorogi Psychiatric Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Himorogi Psychiatric Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Himorogi Psychiatric Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Himorogi Psychiatric Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".